Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-046010
Filing Date
2021-07-08
Accepted
2021-07-08 17:24:38
Documents
2
Period of Report
2021-07-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1665
2 POA DOCUMENT poa.txt EX-24.3_998372 3531
  Complete submission text file 0001209191-21-046010.txt   6685
Mailing Address 1700 E ST ANDREW PLACE SANTA ANA CA 92705
Business Address
TRENARY C RUSSELL III (Reporting) CIK: 0001227307 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37759 | Film No.: 211081027

Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Issuer) CIK: 0001649989 (see all company filings)

EIN.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)